×
App Icon
The Standard e-Paper
Kenya’s Boldest Voice
★★★★ - on Play Store
Download App

NHIF members can now access enhanced prostate cancer drug

NHIF Building, Nairobi. [Jonah Onyango, Standard]

Prostate cancer patients covered by the National Hospital Insurance Fund (NHIF) can now access a new drug that enhances treatment.

The drug, Abiraterone Acetate, from Janssen Kenya, is used for treating advanced prostate cancer and will be available to NHIF members within their benefits package after an agreement between NHIF and Janssen Kenya.

Get Full Access for Ksh299/Week.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in